Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
195,227
-2,843
-1% -$17.2K 0.01% 911
2026
Q1
$1.21M Buy
198,070
+20,094
+11% +$110K 0.01% 794
2025
Q4
$848K Sell
177,976
-2,502
-1% -$12.1K 0.01% 889
2025
Q3
$871K Buy
180,478
+30,784
+21% +$130K 0.01% 894
2025
Q2
$638K Buy
149,694
+5,910
+4% +$22.9K 0.01% 922
2025
Q1
$498K Sell
143,784
-126,428
-47% -$403K 0.01% 1034
2024
Q4
$751K Buy
270,212
+100,501
+59% +$307K 0.01% 764
2024
Q3
$544K Buy
169,711
+48,925
+41% +$156K 0.01% 879
2024
Q2
$315K Buy
120,786
+13,933
+13% +$40.8K 0.01% 1108
2024
Q1
$349K Sell
106,853
-41,407
-28% -$126K 0.01% 961
2023
Q4
$438K Buy
148,260
+1,969
+1% +$5K 0.01% 837
2023
Q3
$344K Buy
+146,291
New +$332K 0.01% 841

Other funds holding SBS

Vident Advisory's SBS Position: Q2 2026 in Review

Vident Advisory reduced its Sabesp (SBS) stake by 1.4% in Q2 2026, selling an estimated $17.2K and leaving 195,227 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #911.

Vident Advisory first reported a position in SBS in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.21M in Q1 2026. 297 funds tracked by Wall St. Rank hold SBS as of Q2 2026.

  • Vident Advisory held 195,227 shares of Sabesp worth $1.13M as of Q2 2026.
  • Vident Advisory sold 2,843 Sabesp shares in Q2 2026, an estimated $17.2K.
  • Sabesp made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #911 holding.
  • Vident Advisory first reported a position in Sabesp in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's Sabesp position peaked at $1.21M in Q1 2026.
  • 297 funds tracked by Wall St. Rank held Sabesp as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.